RESHAPE LIFESCIENCES
ReShape Lifesciences is America's premier weight-loss solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease. The FDA-approved Lap-Band® System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. The ReShape Vest™ System is an investigational (outside the U.S.) minimally invasive, laparoscopically implanted medical device that wraps around the stomach, emulating the gastric volume reduction effect of conventional weight-loss surgery. It helps enable rapid weight loss in obese and morbidly obese patients without permanently changing patient anatomy. T
RESHAPE LIFESCIENCES
Industry:
Biotechnology Health Care Medical Device
Founded:
2005-01-01
Address:
San Clemente, California, United States
Country:
United States
Website Url:
http://www.reshapelifesciences.com
Total Employee:
51+
Status:
Active
Contact:
844-937-7374
Total Funding:
172.05 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Impel NeuroPharma
Impel NeuroPharma is a medical device company that develops a novel drug delivery device that uses direct nose-to-brain delivery.
Autonomous Medical Devices
Autonomous Medical Devices is a developer of a medical device designed to detect pathogens and viruses.
Current Advisors List
Board_member
Board_member
Board_member
Board_member
Board_member
Board_member
Board_member
2009-06-01
Current Employees Featured
Bart Bandy CEO and President @ ReShape Lifesciences
CEO and President
2019-04-01
Dov Gal Vice President, Regulatory and Clinical Affairs @ ReShape Lifesciences
Vice President, Regulatory and Clinical Affairs
Mark B. Knudson President and Chief Executive Officer @ ReShape Lifesciences
President and Chief Executive Officer
Rajesh Nihalani CTO @ ReShape Lifesciences
CTO
Janel Birk VP, Research, Development & Operations @ ReShape Lifesciences
VP, Research, Development & Operations
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-01-20 | Obalon Therapeutics | Obalon Therapeutics acquired by ReShape Lifesciences | N/A |
Investors List
U.S. Venture Partners
U.S. Venture Partners investment in Post-IPO Equity - ReShape Lifesciences
HealthCor Partners
HealthCor Partners investment in Post-IPO Equity - ReShape Lifesciences
New Leaf Venture Partners
New Leaf Venture Partners investment in Post-IPO Equity - ReShape Lifesciences
Venture Investors
Venture Investors investment in Post-IPO Equity - ReShape Lifesciences
SV Health Investors
SV Health Investors investment in Post-IPO Equity - ReShape Lifesciences
Endeavour Vision
Endeavour Vision investment in Post-IPO Equity - ReShape Lifesciences
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - ReShape Lifesciences
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - ReShape Lifesciences
Venture Investors
Venture Investors investment in Post-IPO Equity - ReShape Lifesciences
SV Health Investors
SV Health Investors investment in Post-IPO Equity - ReShape Lifesciences
Official Site Inspections
http://www.reshapelifesciences.com
Unable to get host informations!!!
More informations about "ReShape Lifesciences"
ReShape Lifesciences - Crunchbase Company Profile …
ReShape Lifesciences announced the first surgeries utilizing their next-generation Lap-Band 2.0 FLEX. Additionally, ReShape Lifesciences entered into a merger agreement with Vyome Therapeutics and an asset purchase …See details»
Meet the ReShape Lifeciences Team | ReShape Lifesciences, Inc.
Vipul Shah Senior Vice President, Operations and R&D. Mr. Shah joined the Company as Vice President of Operations and R&D in February 2018. With more than 20 years of experience in …See details»
ReShape Lifesciences, Inc. - American Society for …
The ReShape Lap-Band®, ReShape Lap-Band® 2.0 FLEX, & ReShape Calibration Tubes™. Category Medical Device Contact Information ReShape Lifesciences, Inc.18 Technology Drive, Suite 110Irvine, CA 92618No. …See details»
ReShape Lifesciences Inc. - LinkedIn
ReShape Lifesciences Inc. is America’s premier weight-loss and metabolic health-solutions company, offering an integrated approach to managing and treating obesity.See details»
ReShape Lifesciences - Overview, News & Similar companies
ReShape Lifesciences contact info: Phone number: (949) 429-6680 Website: www.reshapelifesciences.com What does ReShape Lifesciences do? Founded in 2002, …See details»
ReShape Lifesciences Inc. - edgein.io
ReShape Lifesciences Inc. is America’s premier weight-loss and metabolic health-solutions company, offering an integrated approach to managing and treating obesity. The FDA …See details»
Reshape Lifesciences Inc. - Buzzfile
This organization has been operating for approximately 22 years. Reshape Lifesciences is estimated to generate $11.2 million in annual revenues, and employs approximately 1 people …See details»
ReShape Lifesciences® to Announce Financial Results for the First ...
Mar 31, 2024 For more information, please visit www.reshapelifesciences.com. CONTACTS: ReShape Lifesciences Contact: Paul F. Hickey President and Chief Executive Officer 949-276 …See details»
ReShape Lifesciences® Provides Update on Merger Agreement …
4 days ago Transactions Continue to Progress and Remain on TrackIRVINE, Calif. and CAMBRIDGE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. …See details»
ReShape Lifesciences Company Profile | Management and
Www.reshapelifesciences.com . ReShape Lifesciences Profile and History. Founded in 2002, ReShape Lifesciences is a developer of minimally invasive medical devices that treat obesity …See details»
Reshape Lifesciences LLC - VentureRadar
"ReShape Lifesciences, Inc. is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. St. Paul, Minnesota October 23, 2017 – EnteroMedics Inc. …See details»
ReShape Lifesciences Inc. (RSLS) Company Profile & Overview
Nov 15, 2007 Ticker Symbol: RSLS: Exchange: NASDAQ: Fiscal Year: January - December: Reporting Currency: USD: CIK Code: 0001371217: CUSIP Number: 761123603: ISIN …See details»
REPRINTED FROM JUNE 13, 2022 - ReShape Lifesciences
A tremendous amount of work, but the entire organization was behind it, all in. We knew it was the right thing to do based upon our own metrics, plus the historical inflection points and metrics …See details»
ReShape Lifesciences - Craft
Oct 29, 2024 ReShape Lifesciences has 2 employees across 2 locations and $11.3 m in annual revenue in FY 2020. See insights on ReShape Lifesciences including office locations, …See details»
ReShape Lifesciences - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
ReShape Lifesciences Inc. and Vyome Therapeutics Announce
4 days ago www.reshapelifesciences.com, or by sending a written request to ReShape at 18 Technology Drive, Suite 110, Irvine, California 92618, Attention: Corporate Secretary.See details»
ReShape Lifesciences™ Reports Year Ended 2021 Financial and …
Dec 31, 2021 Additionally, payroll related expenditures increased by $0.4 million as the Company strengthened its commercial organization and commissions increased by $0.2 …See details»
ReShape Lifesciences® Provides Update on Merger Agreement …
Jul 9, 2024 Investors and stockholders may obtain a free copy of these materials (when they are available) and other documents filed by ReShape with the SEC at the SEC’s website at …See details»
ReShape Medical, Inc. Completes $38 Million Series D Financing
Aug 26, 2015 18 Technology Drive Suite 110 Irvine, CA 92618. 1-844-YES-RESHAPE 1-844-937-7374 info@ ReShapeLifesci.comSee details»
ReShape Lifesciences™ Reports Third Quarter 2022 Financial …
Sep 30, 2022 Conference Call to be Held at 8:00 am ET Today. SAN CLEMENTE, Calif., Nov. 14, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier …See details»